课题基金 / 基金详情

Genomic risk stratification of chronic kidney disease in renal transplantation and beyond

Genomic risk stratification of chronic kidney disease in renal transplantation and beyond
肾移植及其他慢性肾病的基因组风险分层
批准号:
451693578
负责人:
Professor Dr. Jan Halbritter
金额:
$0.0万
依托单位国家:
德国
项目类别:
Heisenberg Grants
财政年份:
--
资助国家:
德国
项目状态:
未结题
起止时间:

项目摘要

项目成果

Professor Dr. Jan Halbritter的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The precondition for a Heisenberg Programme funding is high scientific quality and originality of the research project at international level and suitability for further qualification as a university teacher. Applicants need to meet all the requirements for appointment to a permanent professorship.The aim of this programme is to enable outstanding scientists to prepare for a scientific leadership function, and simultaneously work on further research topics. This research does not necessarily need to be planned and carried out in the form of a project.For this reason, and unlike the procedure in other funding programmes, both the abstracts of applications and final reports are not required and will therefore not be published in GEPRIS.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
High-throughput mutation analysis for known and novel single-gene causes of kidney stones and related disorders
Assessing genetic risk of post-kidney transplantation malignancy - a pilot study (KTx-Cancer)
  • 批准号:
    471294925
  • 项目类别:
    Research Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    Professor Dr. Jan Halbritter
  • 依托单位:
The role of SLC7A13/AGT1-variation in human cystinuria
Multicenter evaluation of undetermined end-stage renal disease prior to kidney transplantation
国内基金
海外基金
The Heterogenous Impact of Monetary Policy on Firms' Risk and Fundamentals
面向人工智能生成内容的风险识别与治理策略研究
  • 批准号:
    72304290
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2023
  • 负责人:
    向安玲
  • 依托单位:
基于影像代谢重塑可视化的延胡索酸水合酶缺陷型肾癌危险性分层模型的研究
  • 批准号:
    82371912
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    吴广宇
  • 依托单位:
基于移动健康技术干预动脉粥样硬化性心血管疾病高危人群的随机对照现场试验:The ASCVD Risk Intervention Trial
  • 批准号:
    81973152
  • 项目类别:
    面上项目
  • 资助金额:
    54.0万元
  • 批准年份:
    2019
  • 负责人:
    胡东生
  • 依托单位: